Related by context. All words. (Click for frequent words.) 78 severe hepatic impairment 76 severe renal impairment 73 moderate hepatic impairment 72 MULTAQ 72 hepatic insufficiency 70 severe hepatic insufficiency 70 renal impairment 70 mild hepatic impairment 69 moderate renal impairment 68 BYSTOLIC 68 severe renal insufficiency 68 APTIVUS r 68 PREZISTA r 67 primary hypercholesterolemia 67 ACTOplus met XR 67 ACTOplus met 66 VIIBRYD 66 BENICAR HCT 66 NUCYNTA R 66 administering XIFAXAN 66 HMG CoA reductase inhibitors 65 hypomagnesemia 65 renal dysfunction 65 EFFEXOR XR 65 NIASPAN 65 renal insufficiency 65 hypercalcemia 65 coadministration 65 nephrotoxicity 65 APTIVUS ritonavir 65 coadministered 65 methimazole 65 NPH insulin 65 mixed hyperlipidemia 65 benazepril 65 β blocker 64 PRISTIQ 64 CrCl 64 NUCYNTA ® 64 mild renal insufficiency 64 hyperkalemia 64 myopathy rhabdomyolysis 64 metformin accumulation 64 thyrotoxicosis 64 risperidone Risperdal 64 flutamide 64 lipid lowering agents 64 atherothrombotic events 64 INVANZ 64 orthostatic hypotension 64 AZILECT 64 strong CYP#A# inducers 64 oral antidiabetic medication 64 impaired renal 64 NYHA Class II 64 MAO inhibitors 64 COREG 64 ULTRAM ER 64 known sulfonamide allergy 64 refractory gout 64 venlafaxine Effexor 64 transaminase elevations 64 Lactic acidosis 64 monoamine oxidase inhibitors MAOIs 64 pyrexia mucositis sepsis febrile 63 REBETOL therapy 63 OADs 63 TNF antagonist 63 insulin detemir 63 receiving INTRON 63 β blockers 63 pioglitazone HCl 63 severe hepatomegaly 63 LATUDA 63 PROCRIT 63 creatinine clearance 63 metformin sulfonylurea 63 INVEGA R 63 primary generalized tonic 63 corticosteroid therapy 63 PREZISTA 63 hyperphenylalaninemia HPA due 63 FASLODEX 63 nonhematologic adverse reactions 63 hematologic toxicity 63 NUCYNTA TM 63 administered concomitantly 63 heparin induced thrombocytopenia 63 Hypersensitivity reactions 63 thromboembolic events 63 elevated serum creatinine 63 venous thromboembolic events 63 TMP SMX 63 AGILECT R 63 lactic acidosis 63 Mg Uk 63 cytopenias 63 monoamine oxidase inhibitors 63 acarbose 63 ARIXTRA 63 valsartan amlodipine 63 aldosterone antagonist 63 biologic DMARD 63 quetiapine Seroquel 63 ATACAND 62 REYATAZ 62 Erythropoietic therapies may 62 potentially hepatotoxic 62 receiving VELCADE 62 purpura ITP 62 ribavirin therapy 62 danazol 62 LOVENOX R 62 hepatic dysfunction 62 pyridostigmine 62 Serious adverse reactions 62 antiarrhythmic drugs 62 alpha interferons 62 unstable angina pectoris 62 efalizumab 62 voriconazole 62 COPEGUS therapy 62 severe hypersensitivity reactions 62 induce orthostatic hypotension 62 candidemia 62 sertraline Zoloft 62 COPD exacerbation 62 hypocalcemia 62 candesartan cilexetil 62 hypoglycaemic episodes 62 DOXIL 62 PRADAXA 62 generalized edema 62 hypercholesterolaemia 62 potassium sparing diuretics 62 hallucinations dyskinesia 62 neutropaenia 62 antiplatelet medications 62 TEAEs 62 monoamine oxidase inhibitor MAOI 62 SUSTIVA 62 homozygous familial hypercholesterolemia 62 impaired hepatic 62 tamsulosin 62 INVEGA ® 62 electrolyte abnormalities 62 Myelosuppression 62 saline placebo 62 secondary hyperparathyroidism 62 thromboembolic complications 62 hepatotoxicity 62 anakinra 62 hypervolemic hyponatremia 62 metformin sulfonylureas 62 hypophosphatemia 62 bone marrow reticulin deposition 62 euvolemic 62 pimozide 62 thiazolidinedione 62 insulin secretagogue 61 adrenal suppression 61 hepatic function 61 aspartate aminotransferase AST 61 citalopram Celexa 61 QTc prolongation 61 aminotransferases 61 KETEK 61 oral antidiabetic agents 61 AVELOX 61 mycophenolate mofetil 61 haloperidol Haldol 61 leukemia AML 61 aripiprazole Abilify 61 KALETRA 61 invasive candidiasis 61 RLAI 61 LEXIVA 61 REVLIMID ® 61 chronic eosinophilic leukemia 61 Peripheral edema 61 administering VIVITROL 61 aldosterone antagonists 61 systemic corticosteroids 61 Adalimumab 61 gout flares 61 myelosuppression 61 loop diuretics 61 DULERA 61 T2DM 61 prolonged QT interval 61 pancreatic insufficiency 61 Fibrates 61 EXJADE 61 SPRYCEL 61 serum phosphate 61 quinidine 61 antidiabetic drugs 61 acitretin 61 steroid dexamethasone 61 norgestimate 61 Eltrombopag 61 SHPT 61 extrapyramidal symptoms 61 TORISEL 61 chronic immune thrombocytopenic 61 mcg kg REBETOL 61 Adverse reactions 61 KAPIDEX 61 antiarrhythmic drug 61 8mg/kg 61 NOLVADEX 61 JANUMET 61 proliferative diabetic retinopathy 61 CNS depressants 61 #.#mg/dL 61 #mg dose [003] 61 abacavir lamivudine 61 clozapine Clozaril 61 hypersensitivity reaction 61 Infusion Reactions Severe 61 pentoxifylline 61 tricyclic antidepressants 61 paroxetine Paxil 61 diabetic gastroparesis 61 intravenous bisphosphonates 61 thiazide diuretic 61 Primary Hypercholesterolemia 61 oral levofloxacin 61 systemic corticosteroid 61 ALT flares 61 pharyngitis tonsillitis 61 posaconazole 61 QT prolongation 61 serum potassium levels 61 intracranial hemorrhage ICH 60 receiving XGEVA 60 divalproex sodium 60 salmeterol fluticasone 60 hypoglycemic events 60 antihypertensive medications 60 Navelbine ® 60 mcg QD 60 Torsades de Pointes 60 NovoLog ® Mix 60 leukotriene receptor antagonists 60 non metastatic osteosarcoma 60 INCB# [003] 60 fluticasone salmeterol 60 hyperbilirubinemia 60 #mg/day [002] 60 nitrofurantoin 60 INFERGEN 60 oral antidiabetic drugs 60 Thrombocytopenia 60 eosinophilic asthma 60 chronic metabolic acidosis 60 left ventricular dysfunction 60 serum calcium levels 60 IXEMPRA 60 rheumatoid arthritis osteoarthritis ankylosing 60 unresectable HCC 60 metformin HCl 60 serum phosphorous 60 delayed CINV 60 amlodipine beta blockers 60 rosiglitazone maleate 60 leucopenia 60 nevirapine Viramune 60 primary Restless Legs 60 dermatologic reactions 60 severe exacerbations 60 INVEGA 60 fluoxetine paroxetine 60 Telithromycin 60 thrombocytosis 60 HeFH 60 recurrent ischemia 60 oxycodone CR 60 ZIAGEN 60 hyperammonemia 60 Chronic ITP 60 symptomatic hypotension 60 irbesartan 60 postoperative AF 60 receiving immunosuppressive therapy 60 paricalcitol 60 gliclazide 60 autoantibody positive 60 vWD 60 HBeAg negative 60 stage IIIB 60 RISPERDAL 60 partial onset seizures 60 adrenal insufficiency 60 concomitant medications 60 CIMZIA ™ 60 hypercholesterolemic patients 60 hyperprolactinemia 60 paroxetine sertraline 60 metabolic alkalosis 60 salmeterol HFA MDI 60 Parnate 60 salmeterol inhalation powder 60 ARCALYST ® 60 H2 receptor antagonists 60 LEVAQUIN 60 NATRECOR R 60 pulmonary exacerbations 60 serotonergic drugs 60 NOXAFIL 60 treatment emergent hyperglycemia 60 nephrotoxic drugs 60 cerebrovascular events 60 ULORIC 60 SAPHRIS 60 nicardipine 60 laboratory abnormalities 60 NYHA Class III 60 atherogenic dyslipidemia 60 ARCOXIA 60 generalized seizures 60 rFVIIa 60 primidone 60 torsade de pointes 60 Elitek 60 dopaminergic therapy 60 endometrial hyperplasia 60 tumor lysis syndrome 60 ACE Inhibitors 60 Dementia Related Psychosis 60 #mg/day [001] 60 Capecitabine 60 bone marrow suppression 60 lispro 60 folinic acid 60 ZYVOX 60 SUBOXONE 60 Keppra R 60 Oral corticosteroids 60 mcg BID 59 elevated transaminases 59 atypical antipsychotic medications 59 Exacerbations 59 SUSTENNA TM 59 reflux symptoms 59 omeprazole Prilosec 59 thromboembolism 59 EMEND 59 Exacerbation 59 TOPAMAX 59 morphometric vertebral fractures 59 VAPRISOL 59 fulminant hepatitis 59 chlorpheniramine 59 Hypokalemia 59 carbamazepine Tegretol 59 IV bolus 59 myoclonic seizures 59 clonic seizures 59 NORVIR 59 INVEGA ™ 59 umol L 59 symptomatic BPH 59 fosamprenavir 59 Pioglitazone 59 nonvertebral fracture 59 chronic thromboembolic pulmonary 59 virologic failure 59 highly emetogenic 59 analgesic medications 59 invasive fungal infections 59 verapamil 59 myocardial infarction ventricular fibrillation 59 CONCERTA 59 antidiabetic medication 59 onset diabetes mellitus 59 sotalol 59 INTELENCE 59 PAOD 59 deletion 5q cytogenetic abnormality 59 metabolic acidosis 59 symptomatic VTE 59 left ventricular hypertrophy 59 Toxicities 59 AVANDIA 59 hypokalemia hypomagnesemia 59 ischemic complications 59 serum phosphorus 59 decompensated liver disease 59 DMARDS 59 renal toxicity 59 LYSTEDA 59 lopinavir r arm 59 fluid overload 59 relapsing MS 59 anaphylactoid reactions 59 myeloproliferative diseases 59 ALT elevations 59 renal function 59 HIV HCV coinfected 59 NUCYNTA ™ 59 artery stenosis 59 calculated creatinine clearance 59 dosing frequency 59 neuroleptics 59 Paliperidone 59 oral corticosteroid 59 elevated creatinine 59 Angioedema 59 Ribavirin causes 59 JANUVIA 59 Nebulized 59 tolvaptan 59 NATRECOR ® 59 hypertension congestive heart 59 deep venous thromboses 59 Calcium intake 59 ACTEMRA TM 59 ORENCIA ® 59 gemfibrozil 59 five MDS subtypes 59 serum creatinine levels 59 glucocorticoid therapy 59 mixed dyslipidemia 59 glycated hemoglobin levels 59 ruboxistaurin 59 gastrointestinal toxicity 59 Acute Bacterial Sinusitis ABS 59 H2 blockers 59 vasomotor symptoms 59 acutely decompensated congestive heart 59 headache abdominal pain 59 desmopressin 59 Paxil paroxetine 59 torsades de pointes 59 4mg/kg 59 hematologic adverse 59 highly emetogenic chemotherapy 59 FluCAM arm 59 indinavir 59 Tylenol acetaminophen 59 RISPERDAL ® 59 events AEs 59 narrow angle glaucoma 59 CTAP# Capsules 59 Acetaminophen Tylenol 59 prolactin levels 59 corticosteroid dose 59 macular edema secondary 59 onset seizures 59 ziprasidone Geodon 58 sulphonylureas 58 tricyclic antidepressant 58 oxcarbazepine 58 oral prednisolone 58 HBV infections 58 SGPT 58 ADCIRCA 58 valvular disease 58 hemorrhagic cystitis 58 intra articular injection 58 SCIg 58 MAO inhibitor 58 beta2 agonist 58 systemic hypotension 58 events SAEs 58 Postoperative complications 58 antiepileptics 58 Retreatment 58 HC APAP 58 diclofenac Voltaren 58 tranylcypromine 58 variceal bleeding 58 serum phosphate levels 58 lactase deficiency 58 anemia hemoglobin 58 flecainide 58 posterior uveitis 58 Sycrest 58 vardenafil Levitra 58 Renal impairment 58 overactive bladder symptoms 58 tapentadol ER 58 post herpetic neuralgia PHN 58 antidiabetic drug 58 amphotericin B 58 myelodysplastic syndromes MDS 58 lupus nephritis 58 #mg doses [002] 58 dyslipidaemia 58 adriamycin 58 mucocutaneous reactions 58 liver dysfunction 58 immune idiopathic thrombocytopenic 58 antihypertensive therapy 58 necrotizing pancreatitis 58 hepatic failure 58 onset idiopathic hypogonadism 58 Victoza R 58 myalgia arthralgia 58 cirrhotic patients 58 lamotrigine 58 budesonide pMDI 58 oral antidiabetes 58 cIAI 58 non valvular atrial 58 fluoxetine Prozac 58 myelodysplastic syndrome MDS 58 Heterozygous Familial Hypercholesterolemia 58 Atacand 58 tibolone 58 conventional antipsychotics 58 atrophic gastritis 58 tapentadol IR 58 serum calcium 58 infliximab Remicade 58 tipranavir r 58 hypertriglyceridemia 58 VIBATIV 58 MEVACOR 58 Thiazolidinediones 58 Lamictal XR 58 fasting triglyceride levels 58 ischemic cardiomyopathy 58 thrombocytopenia neutropenia 58 HbA1c levels 58 unfavorable cytogenetics 58 angina pectoris 58 elevated ALT 58 haematologic 58 Topiramate 58 enalapril 58 hypoglycemic episodes 58 serum urate 58 urticaria hives 58 pulmonary hypertension PH 58 antithrombotic therapy 58 invasive aspergillosis 58 Hypotension 58 subependymal giant cell 58 beta blocker therapy 58 ONGLYZA 58 serum potassium 58 mu opioid agonists 58 drugs NSAIDS 58 hypokalemia 58 certolizumab 58 HBeAg negative patients 58 chlorambucil 58 non selective NSAIDs 58 Zavesca R 58 quinine sulfate 58 reduce serum phosphate 58 anticoagulant warfarin 58 sulphonylurea 58 severe neutropenia 58 FROVA 58 discontinuations due 58 bronchospasm 58 Soriatane 58 Thal Dex 58 aspartate aminotransferase 58 thioridazine 58 Clinically significant 58 clomipramine 58 bolus dose 58 chronic HCV infection 58 thiazide 58 Cariprazine 58 baseline HbA1c 58 atazanavir 58 serum aminotransferase levels 58 KAPVAY ™ 58 included exfoliative dermatitis 58 REYATAZ r arm 58 aminotransferase levels 58 containing LABAs 58 juvenile idiopathic arthritis 58 elevated IOP 58 cardiovascular disease cerebrovascular disease 58 dapagliflozin plus 58 prescription laxative 58 topical steroid 58 T1DM 57 Non Alcoholic Steatohepatitis 57 constipation nausea 57 Severe hypoglycemia 57 budesonide formoterol 57 FRAGMIN R 57 elevated LDL cholesterol 57 QTc 57 vomiting PONV 57 angiotensin converting enzyme ACE 57 treprostinil 57 events TEAEs 57 dose limiting toxicities 57 Juvenile Idiopathic Arthritis 57 Kepivance 57 eplerenone 57 alpha blocker 57 rosuvastatin #mg 57 COZAAR 57 ergotamine 57 hemorrhagic complications 57 serum sodium 57 neuropsychiatric symptoms 57 urate lowering therapy 57 ketoacidosis hyperosmolar coma 57 Ileus 57 generalized tonic clonic seizures 57 REMICADE ® 57 q#h 57 metformin Glucophage 57 post operative ileus 57 zidovudine lamivudine 57 tirofiban 57 CANCIDAS 57 nonvertebral fractures 57 rizatriptan 57 certolizumab pegol 57 diarrhea nausea vomiting 57 poor metabolizers 57 colorectal adenoma 57 acetominophen 57 Acetate Rectal Suppositories 57 Valproate 57 denileukin diftitox 57 aripiprazole 57 octreotide LAR 57 teratogenic 57 Prilosec omeprazole 57 typical antipsychotics 57 hyperlipidemia hypertension 57 debilitating complication 57 hour bronchodilation 57 proliferative retinopathy 57 GH deficiency 57 MYCAMINE 57 serotonin reuptake inhibitors 57 periprocedural 57 juvenile myoclonic epilepsy 57 SMZ TMP 57 hyperpyrexia 57 PREMPRO 57 ketorolac 57 dose colchicine 57 lipid parameters 57 hypercalciuria 57 Tiotropium 57 thromboprophylaxis 57 ACE inhibitor ramipril 57 atopic eczema 57 platelet inhibition 57 leukopenia 57 zolmitriptan 57 del 5q MDS 57 upper gastrointestinal bleeding 57 QTc intervals 57 acute decompensation 57 hepatorenal syndrome 57 hypertension diabetes mellitus 57 severe oral mucositis 57 hemodynamically significant 57 severe hypoglycaemia 57 sulfonylurea 57 alanine aminotransferase 57 phenobarbital phenytoin 57 intermittent claudication 57 GnRH agonist 57 phenytoin 57 CYP #A# 57 adjunctive placebo 57 proteinuria 57 hematological parameters 57 biphasic insulin aspart 57 variceal hemorrhage 57 MAOIs 57 quinolone antibiotics 57 antiplatelet drugs 57 INVEGA ® SUSTENNA ® 57 pericardial effusions 57 paliperidone 57 metastatic RCC 57 gastrointestinal adverse reactions 57 dopamine antagonists 57 adjunctive ABILIFY 57 fatal anaphylactic 57 acute peptic ulcer 57 sulfonylurea medicine 57 INTEGRILIN R 57 mcg mL 57 overt nephropathy 57 cerebrovascular accident 57 antihypertensive drugs 57 oral corticosteroids 57 AIOD 57 glucocorticoid induced osteoporosis 57 acute gout flares 57 AST ALT 57 systolic hypertension 57 myocardial infarction stroke 57 discontinued Viread 57 BANZEL 57 recurrent VTE 57 mL/min/#.# m 2 57 High Dose quadruples 57 ketoconazole 57 retinal vein occlusion 57 PPSV# 57 HPA axis suppression 57 unresectable recurrent 57 Chronic HCV 57 heterozygous FH 57 Ranolazine 57 elevated triglycerides 57 receiving PEGINTRON 57 complement inhibitor eculizumab 57 histologic subtype 57 Hyperkalemia 57 hypotension 57 EDARBI 57 Major Depressive Disorder 57 tegaserod 57 glycosylated hemoglobin levels 57 glulisine 57 hyperglycaemia 57 AA Amyloidosis 57 Lantus ® 57 failure ADHF 57 hepatic cirrhosis 57 glycosylated hemoglobin HbA1c 57 autoimmune disorder characterized 57 hypercholesterolemia 57 pheochromocytoma 57 5-FU/LV 57 thrombotic events 57 sympathomimetic amines 57 QT interval prolongation 57 polyp recurrence 57 antiemetics 57 somnolence dizziness 57 VIMOVO 56 IV NSCLC 56 cardiovascular hospitalization 56 nonfatal stroke 56 headache nasopharyngitis 56 solifenacin 56 methemoglobinemia 56 nonischemic 56 ximelagatran 56 infliximab monotherapy 56 TNF blockers 56 GEMZAR 56 urinary symptoms 56 macrolide antibiotic 56 fluvastatin Lescol 56 RoACTEMRA 56 lipid disorders 56 abatacept 56 GnRH agonists 56 olmesartan 56 osteoarthritis rheumatoid arthritis 56 juvenile idiopathic arthritis JIA 56 cetirizine 56 hypertension systolic blood 56 plasma uric acid 56 Ozarelix 56 fibromyalgia syndrome 56 thiazides 56 Eisenmenger syndrome 56 autoantibody levels 56 Severe cutaneous 56 alpha blockers 56 detrusor overactivity 56 anticonvulsant medications 56 pericardial effusion 56 androgen deprivation 56 cidofovir 56 oral vancomycin 56 Cervical Dystonia 56 Aggrastat ® tirofiban hydrochloride 56 relapsing remitting 56 diuretic chlorthalidone 56 6R BH4 56 Pramipexole 56 Acute Exacerbations 56 hypercalcaemia 56 hyperreflexia 56 TOPAMAX ® 56 ziconotide 56 CYP#A# substrate 56 nitroprusside 56 hyperphosphatemia 56 diarrhea vomiting nausea 56 OsmoPrep 56 Tardive dyskinesia 56 Hyperphosphatemia 56 nadolol 56 titrated glipizide 56 Neupro R 56 elevated plasma concentrations 56 Hepatotoxicity 56 triglyceride concentrations 56 sodium glucose cotransporter 56 CMV infection 56 DETROL LA 56 thromboembolic 56 gemifloxacin 56 COPD exacerbations 56 nondiabetic patients 56 anticonvulsants 56 ARICEPT 56 Glucocorticoids 56 Nesiritide 56 piroxicam 56 arterial thromboembolic events 56 hyperoxaluria 56 ALVESCO 56 ORENCIA 56 pancytopenia 56 severe hypoglycemia 56 ddI 56 lichen planus 56 adverse reactions incidence 56 bezafibrate 56 PGTC seizures 56 topical corticosteroids 56 stable angina 56 post thrombotic syndrome 56 metformin hydrochloride 56 nonalcoholic steatohepatitis 56 gestational hypertension 56 olanzapine Zyprexa 56 cholinesterase inhibitor 56 inhaled budesonide 56 adalimumab 56 atorvastatin Lipitor 56 esophagitis 56 terazosin 56 tardive dyskinesia TD 56 headache nausea diarrhea 56 Candesartan 56 EGFRIs 56 hypogonadal men 56 anticholinergics 56 improves glycemic 56 macrovascular complications 56 serum testosterone 56 pruritus itching 56 mEq L 56 quetiapine 56 spironolactone 56 hemoglobin A1c HbA1c 56 hyperalgesia 56 decompensated heart failure 56 tricyclics 56 cardiac toxicity 56 neuroleptic malignant syndrome 56 Neovascular AMD 56 Prehypertension 56 metformin monotherapy 56 Atypical Hemolytic Uremic Syndrome 56 tramadol HCl 56 systemic lupus erythematosus psoriasis 56 psychiatric comorbidities 56 Apidra ® 56 ventricular tachycardia VT 56 bosentan 56 subtrochanteric 56 Geodon ziprasidone 56 C1 inhibitor deficiency 56 recurrent DVT 56 Veramyst 56 arterial thrombosis 56 antiepileptic drug 56 subcutaneous insulin 56 cabergoline 56 annualized relapse 56 REYATAZ ritonavir 56 ARB telmisartan 56 Vaprisol 56 fistulizing CD 56 pioglitazone 56 serum triglyceride levels 56 alanine aminotransferase ALT 56 cerebral vasospasm 56 dosing cohort 56 triglycerides TG 56 adverse reactions ≥ 56 hyperglycemia 56 VYTORIN 56 antidiabetic medications 56 optic neuropathy 56 lacosamide 56 Celebrex celecoxib 56 thiazolidinediones TZDs 56 triiodothyronine 56 nausea diarrhea constipation 56 fibrinolysis 56 antiarrhythmic agents 56 Severe Primary IGFD 56 Effexor venlafaxine 56 elevated LDH 56 QTc interval 56 PPAR gamma agonist 56 cinacalcet 56 inadequate glycemic 56 hereditary antithrombin deficiency 56 congenital ichthyosis 56 NNT = 56 INVEGA ® SUSTENNA TM 56 candesartan 56 mildly symptomatic 56 hypoparathyroidism 56 glitazones 56 Hypoglycemia 56 follicular lymphoma FL 56 terlipressin 56 nonfatal MI 55 vertebral fracture 55 Noxafil 55 quinolones 55 macular edema 55 nephropathy 55 macroalbuminuria 55 alteplase 55 concomitant cardiac 55 ropinirole 55 Long acting beta2 55 antihistamine medicines 55 Hyperlipidemia 55 CRVO 55 Fluid retention 55 elevated intraocular pressure 55 cardiovascular hospitalizations 55 oral antidiabetes drugs 55 SSRI antidepressant 55 MADRS score 55 every ERBITUX infusion 55 coronary stenosis 55 Hypoactive Sexual Desire Disorder 55 GERD symptoms 55 Toviaz 55 tolterodine ER 55 clodronate 55 NEUPOGEN 55 CIMZIA 55 occlusion CRVO 55 ventricular fibrillation VF 55 angiotensin II receptor blockers 55 Streptococcus pneumoniae Haemophilus influenzae 55 NYHA 55 Febrile neutropenia 55 angioneurotic edema 55 EDSS scores 55 NOMID 55 comorbid conditions 55 digoxin toxicity 55 newer atypical antipsychotics 55 coagulation abnormalities 55 CTEPH 55 susceptible isolates 55 reinfarction 55 hypocalcaemia 55 especially coronary insufficiency 55 diarrhea CDAD 55 hematological toxicity 55 Digoxin 55 lipid abnormalities 55 Neupro ® 55 nonfatal myocardial infarction MI 55 Serum creatinine 55 LANTUS R 55 LV dysfunction 55 macrovascular events 55 HBeAg seroconversion 55 disease CDAD 55 dose cohort 55 systemic lupus erythematosus SLE 55 headache nausea fatigue 55 kidney insufficiency 55 glargine 55 nitrofurantoins 55 retinal vein occlusion RVO 55 microgram kg 55 essential thrombocythemia 55 idiopathic thrombocytopenic purpura 55 sodium valproate 55 erythematosus 55 thrombophlebitis 55 prolactin elevation 55 bronchial hyperresponsiveness 55 achieved ACR# 55 vascular occlusive diseases 55 Primary IGFD 55 prescribed opioids 55 lupus erythematosus 55 Helicobacter pylori eradication 55 Tekturna HCT